LKFT LAKEFRONT BIOTHERAPEUTICS NV: institutional ownership and insider trading
81 funds reported holding $981M of LAKEFRONT BIOTHERAPEUTICS NV in their latest 13F filings; in Q2 2026 funds net bought $23.1M, with 8 new positions and 21 funds selling out.
Famous investors holding LKFT
- David Einhorn (Greenlight Capital): $14.5M, 0.4% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $12.2M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $5.93M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $5.43M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.65M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.45M, 0.0% of the portfolio
Largest institutional holders of LKFT
- GILEAD SCIENCES, INC. (GILD) — $500M
- TANG CAPITAL MANAGEMENT LLC — $114M
- Madison Avenue Partners, LP — $103M
- Prosight Management, LP — $61.3M
- EcoR1 Capital, LLC — $50.0M
- AMERIPRISE FINANCIAL INC (AMP) — $38.1M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $18.0M
- DME Capital Management, LP — $14.5M
- RENAISSANCE TECHNOLOGIES LLC — $12.2M
- BlackRock, Inc. (BLK) — $10.1M
5%+ owners
- Madison Avenue International LP: 5.5% (Schedule 13G, filed Jun 23, 2026)